Trump’s health secretary nominee met with Hill staffers ahead of his hearing this week.
Health Care
RFK Jr. says he’s open to seizing drug patents
Health Care
January 27, 2025
ultocalanissan@gmail.com
Related Posts
‘Ridiculously traumatized’: CDC workers fear returning to work after fatal shooting
Agency employees said HHS’s response has been lackluster. Agency employees said HHS’s response has been lackluster. Health Care
RFK Jr. is holding up $600 million in vaccines for poor countries
The distributor of the shots said it would cost tens of thousands of lives. The distributor of the shots said it would cost tens of thousands of lives. Health...
Means defends HHS cuts, calls bureaucracy an ‘utter failure’
He also said the election of Trump was a mandate to make dramatic change in leadership. He also said the election of Trump was a mandate to make dramatic...
It’s now time for the Obamacare blame game
With insurance rates spiking and Congress stalemated, professional advocates are swooping in to shape the narrative. With insurance rates spiking and Congress stalemated, professional advocates are swooping in to...
3 Republican senators signal disapproval of HHS rule change seen as reducing transparency
Post Content Health Care
Lawmakers believe their breakthrough bill will lower drug costs. It may not.
The industry that negotiates drug prices for employers has worked to stay ahead of the game. The industry that negotiates drug prices for employers has worked to stay ahead...
Top vaccine regulator returns to FDA after recent firing
Vinay Prasad had been dismissed less than two weeks ago. Vinay Prasad had been dismissed less than two weeks ago. Health Care
Fear over RFK Jr. vaccine panel’s looming decisions on childhood shots
The panel will discuss the Covid-19, hepatitis B and the measles, mumps, rubella and varicella vaccines, as well as the RSV shot. The panel will discuss the Covid-19, hepatitis...
Top Trump FDA official Brenner hits pause on Novavax Covid-19 vaccine decision
The intervention by a senior FDA official in a product decision is a highly unusual action. The intervention by a senior FDA official in a product decision is a...
Top drug lobbyist to depart PhRMA at year end
The announcement of Steve Ubl’s departure, disclosed at a board call, caps a decade atop the brand drug lobby. The announcement of Steve Ubl’s departure, disclosed at a board...